Litigation Details for Ravgen, Inc. v. Ariosa Diagnostics, Inc. (D. Del. 2020)
✉ Email this page to a colleague
Ravgen, Inc. v. Ariosa Diagnostics, Inc. (D. Del. 2020)
| Docket | ⤷ Try a Trial | Date Filed | 2020-12-02 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | Plaintiff | Referred To | Jennifer L. Hall |
| Patents | 7,727,720 | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Ravgen, Inc. v. Ariosa Diagnostics, Inc.
The biologic drugs covered by the patent cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Ravgen, Inc. v. Ariosa Diagnostics, Inc. (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-12-02 | 1 | Complaint | United States Patent Nos. 7,727,720 (the “’720 Patent”) and 7,332,277 (the “’277 Patent”) (collectively…number of patents and patent applications that are related to subject matter similar to the Patents-in-Suit…Ravgen’s ’277 Patent or the application that matured into Ravgen’s ’277 Patent (U.S. Patent Application…Ravgen’s ’277 Patent or the application that matured into Ravgen’s ’277 Patent (U.S. Patent Application…Ravgen’s ’720 Patent or the application that matured into Ravgen’s ’720 Patent (U.S. Patent Application | External link to document |
| 2021-02-18 | 20 | Complaint - Amended | United States Patent Nos. 7,727,720 (the “’720 Patent”) and 7,332,277 (the “’277 Patent”) (collectively…number of patents and patent applications that are related to subject matter similar to the Patents-in-Suit…Ravgen’s ’277 Patent or the application that matured into Ravgen’s ’277 Patent (U.S. Patent Application…Ravgen’s ’277 Patent or the application that matured into Ravgen’s ’277 Patent (U.S. Patent Application…Ravgen’s ’720 Patent or the application that matured into Ravgen’s ’720 Patent (U.S. Patent Application | External link to document |
| 2023-07-10 | 205 | Report and Recommendations | United States Patent Nos. 7,727,720 (the “ʼ720 patent”), and 7,332,277 (the “ʼ277 patent”). The Court …inhibits] cell lysis” (ʼ277 patent, claims 8, 55, and 81; ʼ720 patent, claim 1) 2 “cell … by the patent, so that interested members of the public, e.g., competitors of the patent owner, can…at the time the patent was filed, and it should be considered in view of the patent’s specification… and 81 of the ʼ277 patent and claim 1 of the ʼ720 patent. Each of those | External link to document |
| 2021-03-19 | 24 | Brief - Opening Brief in Support | U.S. Patent No. 7,727,720 (the “’720 Patent”; collectively with the ’277 Patent, the “Patents-in-Suit…several of the patents in Ravgen’s portfolio,” including the ’720 Patent and the ’277 Patent. Ravgen attached…and RMS infringe claims of U.S. Patent No. 7,332,277 (the “’277 Patent”) and that all Defendants infringe… acts that caused patent infringement. For example, with respect to the ’277 Patent, 2 Ravgen…any patents. On information and belief, after acquiring knowledge of the Patents-in-Suit | External link to document |
| 2021-03-19 | 26 | Brief - Opening Brief in Support | and induced infringement of U.S. Patent No. 7,727,720 (the “’720 Patent”) against Defendant Foundation…two asserted patents—the ’720 Patent and U.S. Patent No. 7,332,277 (the “’277 Patent”); and (3) two …infringed the Patents in-Suit” (id. ¶119), even though only one patent (the ’720 Patent) is asserted …Defendants” participates in patent litigation, patent prosecution, and patent monitoring (D.I. 20, ¶¶ …the ’720 Patent and (2) FMI knew or should have known that it was infringing the ’720 Patent. Case 1 | External link to document |
| 2020-12-02 | 3 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,727,720 B2 ;US 7,332,277 … 3 December 2020 1:20-cv-01646 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| 2021-04-12 | 30 | Brief - Answering Brief in Opposition | including U.S. Patent Nos. 7,332,277 and 7,727,720 (collectively, the “Patents-in-Suit”). D.I. 20 …aware of the Patents-in-Suit for years, cited the Patents-in-Suit in their own patent applications …number of patents and patent applications related to subject matter similar to the Patents-in-Suit and…aware of the Patents-in-Suit in researching the patentability of their own patents. Id. ¶ 79. Additionally…Defendants’ own patent applications demonstrates Defendants’ pre-suit awareness of the Patents-in-Suit. Defendants | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
